Moderna Inc. buy UBS Group AG
Start price
07.05.24
/
50%
€110.94
Target price
07.05.25
€140.14
Performance (%)
10.20%
Price
17.05.24
€122.26
Summary
This prediction is currently active. The prediction currently has a performance of 10.20%. This prediction currently runs until 07.05.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Moderna Inc. | 12.248% |
| iShares Core DAX® | -0.383% |
| iShares Nasdaq 100 | 1.248% |
| iShares Nikkei 225® | 0.525% |
| iShares S&P 500 | 0.640% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target raised by analysts at UBS Group AG from $143.00 to $151.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat